Connect to other sites within the UBM Medica Network
Improving Long-Term Survival in Patients With Locally Advanced Pancreatic Cancer via the Delivery of Definitive Radiotherapy Doses
Five randomized trials involving patients with locally advanced pancreatic cancer illustrate most clearly the substantial degree to which standard therapies are limited in their effectiveness.
Priority Review for MM-398 in Advanced Pancreatic Cancer
The FDA has granted a priority review for MM-398 as a second-line treatment for metastatic pancreatic cancer after the drug demonstrated improved survival.
Marker Could Help Diagnose Early Pancreatic Cancer
Researchers have discovered a protein encoded by the GPC1 gene present on cancer exomes that may be used as a diagnostic tool to detect early pancreatic cancer.
A Nutty Way to Prevent Cancer?
A large review ties nut consumption to a lower incidence of cancer, but not diabetes.
Blood Clots in Abdomen May Be Sign of Cancer
The presence of an abdominal blood clot may be a sign of cancer and may also be associated with poor survival for patients with pancreatic or liver cancers.
Metformin May Not Improve Pancreatic Cancer Survival
Metformin, a common drug for type II diabetes, did not improve the survival of patients with pancreatic ductal adenocarcinoma.
MRI Screening for Individuals at High Risk for Pancreatic Cancer
An MRI screening program for individuals at high risk for pancreatic cancer may be effective, according to the results of a short-term study.
By clicking Accept, you agree to become a member of the UBM Medica Community.